An observational study in Mechanical Ventilation, sponsored by University Hospital, Lille. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-06.
Sponsored by University Hospital, Lille · Observational
The aim of this prospective cohort single-center observational study is to determine the impact of hyperoxemia on ventilator-associated pneumonia (VAP) occurrence.
Patients with VAP will be compared with those with no VAP
2,072 studies on the registry are indexed under Pneumonia; 286 are open to participants now.
This study's enrollment of 534 is above the median of 200 across 699 observational studies indexed under Pneumonia.
Browse Pneumonia studies →University Hospital, Lille is the lead sponsor of 630 studies on the registry; 141 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients hospitalized in intensive care unit requiring invasive mechanical ventilation (IV) for more than 48 hours.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
VAP occurrence
hyperoxemia at ICU admission (PaO2 \>120 mmHg)
Time frame: 28 days after ICU admission
percentage of time spent with hyperoxemia during ICU stay
hyperoxemia is defined as peripheral O2 saturation (SaO2)\>98%, SaO2 will be measured every 30 seconds, and the percentage of time spent with hyperoxemia will be calculated per day.
Time frame: 28 days after ICU admission
relationship between hyperoxemia at ICU admission and the presence of acute lung injury (ALI)
the presence of hyperoxemia at ICU admission will be determined using blood gazes (arterial PaO2\>120 mmHg). The percentage of patients with hyperoxemia will be compared between patients with Ali, and those with no ALI
Time frame: 28 days after ICU admission
percentage of time spent with hyperoxemia during ICU stay, and the presence of acute lung injury
the percentage of time spent with hyperoxemia during ICU stay will be calculated as mentioned above (outcome 2). This percentage will be compared between patient with ALI and those with no ALI
Time frame: 28 days after ICU admission
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.